Biospecimen reporting for improved study quality (BRISQ)
dc.contributor.author | Moore, Helen M. | en_US |
dc.contributor.author | Kelly, Andrea B. | en_US |
dc.contributor.author | Jewell, Scott D. | en_US |
dc.contributor.author | McShane, Lisa M. | en_US |
dc.contributor.author | Clark, Douglas P. | en_US |
dc.contributor.author | Greenspan, Renata | en_US |
dc.contributor.author | Hayes, Daniel F. | en_US |
dc.contributor.author | Hainaut, Pierre | en_US |
dc.contributor.author | Kim, Paula | en_US |
dc.contributor.author | Mansfield, Elizabeth A. | en_US |
dc.contributor.author | Potapova, Olga | en_US |
dc.contributor.author | Riegman, Peter | en_US |
dc.contributor.author | Rubinstein, Yaffa | en_US |
dc.contributor.author | Seijo, Edward | en_US |
dc.contributor.author | Somiari, Stella | en_US |
dc.contributor.author | Watson, Peter | en_US |
dc.contributor.author | Weier, Heinz-Ulrich | en_US |
dc.contributor.author | Zhu, Claire | en_US |
dc.contributor.author | Vaught, Jim | en_US |
dc.date.accessioned | 2011-05-06T15:39:52Z | |
dc.date.available | 2012-05-14T20:40:08Z | en_US |
dc.date.issued | 2011-04-25 | en_US |
dc.identifier.citation | Moore, Helen M.; Kelly, Andrea B.; Jewell, Scott D.; McShane, Lisa M.; Clark, Douglas P.; Greenspan, Renata; Hayes, Daniel F.; Hainaut, Pierre; Kim, Paula; Mansfield, Elizabeth A.; Potapova, Olga; Riegman, Peter; Rubinstein, Yaffa; Seijo, Edward; Somiari, Stella; Watson, Peter; Weier, Heinz-Ulrich; Zhu, Claire; Vaught, Jim (2011). "Biospecimen reporting for improved study quality (BRISQ)." Cancer Cytopathology 119(2): 92-102. <http://hdl.handle.net/2027.42/83764> | en_US |
dc.identifier.issn | 1934-662X | en_US |
dc.identifier.issn | 1934-6638 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/83764 | |
dc.description.abstract | Human biospecimens are subjected to collection, processing, and storage that can significantly alter their molecular composition and consistency. These biospecimen preanalytical factors, in turn, influence experimental outcomes and the ability to reproduce scientific results. Currently, the extent and type of information specific to the biospecimen preanalytical conditions reported in scientific publications and regulatory submissions varies widely. To improve the quality of research that uses human tissues, it is crucial that information on the handling of biospecimens be reported in a thorough, accurate, and standardized manner. The Biospecimen Reporting for Improved Study Quality (BRISQ) recommendations outlined herein are intended to apply to any study in which human biospecimens are used. The purpose of reporting these details is to supply others, from researchers to regulators, with more consistent and standardized information to better evaluate, interpret, compare, and reproduce the experimental results. The BRISQ guidelines are proposed as an important and timely resource tool to strengthen communication and publications on biospecimen-related research and to help reassure patient contributors and the advocacy community that their contributions are valued and respected. Cancer (Cancer Cytopathol) 2011. Published 2011 by the American Cancer Society. | en_US |
dc.publisher | John Wiley & Sons, Inc. | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Cancer Research, Oncology and Pathology | en_US |
dc.title | Biospecimen reporting for improved study quality (BRISQ) | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationother | Office of Biorepositories and Biospecimen Research, National Cancer Institute, Bethesda, Maryland | en_US |
dc.contributor.affiliationother | Rose Li and Associates, Inc, Bethesda, Maryland | en_US |
dc.contributor.affiliationother | Program for Biospecimen Science, Van Andel Research Institute, Grand Rapids, Michigan | en_US |
dc.contributor.affiliationother | Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland | en_US |
dc.contributor.affiliationother | Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland ; Fax: (410) 614-9556 ; The Johns Hopkins Hospital, 600 N. Wolfe Street, PATH 406, Baltimore, MD 21287-6940 | en_US |
dc.contributor.affiliationother | US Military Cancer Institute, Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland | en_US |
dc.contributor.affiliationother | International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France | en_US |
dc.contributor.affiliationother | Paula Kim, Inc, Translating Research Across Communities (TRAC), Solana Beach, California | en_US |
dc.contributor.affiliationother | Center for Devices and Radiological Health, US Food and Drug Administration, US Department of Health and Human Services, Silver Spring, Maryland | en_US |
dc.contributor.affiliationother | Cureline, Inc, South San Francisco, California | en_US |
dc.contributor.affiliationother | Erasmus MC Tissue Bank, Department of Pathology, Rotterdam, Netherlands | en_US |
dc.contributor.affiliationother | Office of Rare Diseases Research, National Institutes of Health, Bethesda, Maryland | en_US |
dc.contributor.affiliationother | H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida | en_US |
dc.contributor.affiliationother | Windber Research Institute, Windber, Pennsylvania | en_US |
dc.contributor.affiliationother | Vancouver Island Center, British Columbia Cancer Agency, Victoria, British Columbia, Canada | en_US |
dc.contributor.affiliationother | Life Sciences Division, Lawrence Berkeley National Laboratory, US Department of Energy, Berkeley, California | en_US |
dc.contributor.affiliationother | Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland | en_US |
dc.contributor.affiliationother | Office of Biorepositories and Biospecimen Research, National Cancer Institute, Bethesda, Maryland | en_US |
dc.identifier.pmid | 21433001 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/83764/1/20147_ftp.pdf | |
dc.identifier.doi | 10.1002/cncy.20147 | en_US |
dc.identifier.source | Cancer Cytopathology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.